New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
August 20, 2025
August 20, 2025
BOSTON, Massachusetts, Aug. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
*
Dana-Farber researchers have provided the mechanistic and preclinical evidence needed to support a clinical trial of a new class of drugs called direct cyclin inhibitors in patients with a range of cancers.
New resear . . .
* * *
New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
*
Dana-Farber researchers have provided the mechanistic and preclinical evidence needed to support a clinical trial of a new class of drugs called direct cyclin inhibitors in patients with a range of cancers.
New resear . . .